Nature Immunology, Published online: 12 March 2026; doi:10.1038/s41590-026-02475-w
A dual-recombinase fate-mapping system enables the permanent labeling of T cells activated during a treatment window, providing insights into the site-specific acquisition of diverse effector functions acquired at different antigen-priming sites.
Read more about this post…
Credits: Source
Disclaimer




Serving